Search Results

Filter
  • 1-10 of  248,705 results for ""BREAST cancer""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

PDP1 promotes the progression of breast cancer through STAT3 pathway.

  • Authors : Wang Y; Department of the First Clinical Medical College, Lanzhou University, Lanzhou, China.; Department of Oncology, Tumor Hospital of Gansu Province, Lanzhou, China.

Subjects: Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/genetics ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/metabolism; Female

  • Source: Cell biochemistry and function [Cell Biochem Funct] 2024 Apr; Vol. 42 (3), pp. e3994.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8305874 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

The PI3K/AKT/mTOR signaling pathway in breast cancer: Review of clinical trials and latest advances.

  • Authors : Khorasani ABS; Department of Hematology, School of Medical Sciences, Tarbiat Modares University, Tehran, Iran.; Hafezi N

Subjects: Phosphatidylinositol 3-Kinase*/Phosphatidylinositol 3-Kinase*/Phosphatidylinositol 3-Kinase*/metabolism ; Phosphatidylinositol 3-Kinase*/Phosphatidylinositol 3-Kinase*/Phosphatidylinositol 3-Kinase*/pharmacology ; Phosphatidylinositol 3-Kinase*/Phosphatidylinositol 3-Kinase*/Phosphatidylinositol 3-Kinase*/therapeutic use

  • Source: Cell biochemistry and function [Cell Biochem Funct] 2024 Apr; Vol. 42 (3), pp. e3998.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8305874 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

Epitranscriptomic orchestrations: Unveiling the regulatory paradigm of m6A, A-to-I editing, and m5C in breast cancer via long noncoding RNAs and microRNAs.

  • Authors : Yin Q; Precision Medicine Laboratory, School of Medical Technology and Engineering, Henan University of Science and Technology, Luoyang, China.; Henan Engineering Research Center of Digital Pathology and Artificial Intelligence Diagnosis, The First Affiliated Hospital of Henan University of Science and Technology, Luoyang, China.

Subjects: MicroRNAs*/MicroRNAs*/MicroRNAs*/genetics ; MicroRNAs*/MicroRNAs*/MicroRNAs*/metabolism ; RNA, Long Noncoding*/RNA, Long Noncoding*/RNA, Long Noncoding*/genetics

  • Source: Cell biochemistry and function [Cell Biochem Funct] 2024 Apr; Vol. 42 (3), pp. e3996.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8305874 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

Therapeutic significance of long noncoding RNAs in estrogen receptor-positive breast cancer.

Subjects: Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/pathology ; RNA, Long Noncoding*/RNA, Long Noncoding*/RNA, Long Noncoding*/genetics; Humans

  • Source: Cell biochemistry and function [Cell Biochem Funct] 2024 Apr; Vol. 42 (3), pp. e3993.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8305874 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

Serum exosomal miR-3662 down-regulates the expression of RBMS3 to promote malignant progression and gemcitabine resistance of breast cancer cells.

  • Authors : Li X; Department of Thyroid and Breast Surgery, Zigong Fourth People's Hospital, Zigong, Sichuan, China.; Chu X

Subjects: Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/pathology ; MicroRNAs*/MicroRNAs*/MicroRNAs*/genetics; Humans

  • Source: Chemical biology & drug design [Chem Biol Drug Des] 2024 Mar; Vol. 103 (3), pp. e14488.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101262549 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

Discrepancies in breast cancer guideline recommendations despite similar Cochrane systematic review conclusions.

  • Authors : Zhang Z; Intensive Care Units, Lanzhou University First Affiliated Hospital, Lanzhou, China.; Evidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou, China.

Subjects: Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/therapy; Humans ; Female

  • Source: Journal of evidence-based medicine [J Evid Based Med] 2024 Mar; Vol. 17 (1), pp. 17-25. Date of Electronic Publication: 2024 Mar 09.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101497477 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

First-line CDK4/6 inhibitor-based combinations for HR+/HER2- advanced breast cancer: A Bayesian network meta-analysis.

  • Authors : Guo X; Department of Breast Surgery and Oncology (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, Key Laboratory of Molecular Biology in Medical Sciences), The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.; Zhejiang Provincial Clinical Research Center for Cancer, Hangzhou, Zhejiang, China.

Subjects: Protein Kinase Inhibitors*/Protein Kinase Inhibitors*/Protein Kinase Inhibitors*/therapeutic use ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/drug therapy ; Aminopyridines*

  • Source: Journal of evidence-based medicine [J Evid Based Med] 2024 Mar; Vol. 17 (1), pp. 106-118. Date of Electronic Publication: 2023 Dec 16.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101497477 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

BRCA1 deficiency enhances the aggressiveness of breast cancer cells expressing HPV16 oncoproteins.

  • Authors : Sangthong J; Faculty of Science, Graduate Program in Molecular Medicine, Mahidol University, Bangkok, Thailand.; Thuwajit C

Subjects: Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/genetics ; Papillomavirus Infections*/Papillomavirus Infections*/Papillomavirus Infections*/genetics ; Oncogene Proteins, Viral*/Oncogene Proteins, Viral*/Oncogene Proteins, Viral*/genetics

  • Source: Biology of the cell [Biol Cell] 2024 Apr; Vol. 116 (4), pp. e202300072. Date of Electronic Publication: 2024 Mar 21.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8108529 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Mucilage-assisted fabrication of molybdenum trioxide nanostructures for photothermal ablation of breast cancer cells.

  • Authors : Alomari RA; Nanobiotechnology and Molecular Biology Research Laboratory, Department of Food Science and Nutrition, College of Food Science and Agriculture, King Saud University, Riyadh, Saudi Arabia.; Athinarayanan J

Subjects: Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/drug therapy ; Nanostructures*/Nanostructures*/Nanostructures*/chemistry ; Oxides*

  • Source: Biotechnology and applied biochemistry [Biotechnol Appl Biochem] 2024 Apr; Vol. 71 (2), pp. 326-335. Date of Electronic Publication: 2023 Dec 19.Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 8609465 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Fine-needle aspiration biopsy of axillary lymph nodes: A reliable diagnostic tool for breast cancer staging.

  • Authors : Sallout L; Department of Pathology and Laboratory Medicine, King Fahad Medical City, Riyadh, Saudi Arabia.; Tashkandi M

Subjects: Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/diagnosis ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/surgery ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/pathology

  • Source: Cancer cytopathology [Cancer Cytopathol] 2024 Feb; Vol. 132 (2), pp. 103-108. Date of Electronic Publication: 2023 OctPublisher: Wiley-Blackwell Country of Publication: United States NLM ID: 101499453 Publication Model: Print-Electronic Cited

Record details

×
  • 1-10 of  248,705 results for ""BREAST cancer""